Nota Informativa Importante su Nimesulide (17/02/2012)
L’Agenzia Italiana del Farmaco rende disponibile on line nuove ed importanti informazioni sui medicinali per uso sistemico contenenti nimesulide.
Undefined
L’Agenzia Italiana del Farmaco rende disponibile on line nuove ed importanti informazioni sui medicinali per uso sistemico contenenti nimesulide.
L’Agenzia Italiana del Farmaco rende disponibile on line nuove ed
importanti informazioni sull’uso estetico della tossina botulinica.
Product marketed as dietary supplement contains drug ingredient Tadalafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.
Monthly Safety Labeling Changes includes 63 products with revisions to Prescribing Information.
Products intended for use in the eye that are non-sterile have the potential to cause eye infections, which may be sight threatening. Also, nasal solutions that are not sterile could lead to a respiratory infection.
Products could potentially expose users and patients to unnecessary and potentially harmful X-rays.
Interactions between Victrelis and ritonavir-boosted atazanavir, lopinavir, and darunavir can potentially reduce the effectiveness of these medicines when co-administered.
L’Agenzia Italiana del Farmaco rende disponibile on line nuove ed
importanti informazioni sull'attuazione di un programma di monitoraggio degli episodi clinicamente rilevanti di ipotensione e degli eventi avversi correlati all’uso di Revatio 0,8 mg/ml soluzione iniettabile.
Symptoms may include watery stool, abdominal pain, and fever. Patients may go on to develop more serious intestinal conditions.
Recalled products pose significant risk to patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.
80.211.154.110